CVTX

CV Therapeutics Challenges Resistance On Increased Volume - 10/07 - 11:35 AM ET

CV Therapeutics Well Supported - 09/17 - 07:10 AM ET

CV Therapeutics Inc licenses Ranexa to Menarini Group in Europe - 09/15 - 04:36 AM ET

Palo Alto s CV Therapeutics signs deal with Italian company to sell angina drug overseas - 09/12 - 04:15 PM ET

CV Therapeutics licenses angina drug to Menarini Group - 09/12 - 01:08 PM ET

CV Therapeutics Climbs In Pre-Market Following New Agreement - 09/12 - 09:17 AM ET

CVTX: Conference call regarding Announces License Agreement for Ranexa(R) in Europe With Menarini Group @ 08:00 ET Today [delayed] - 09/12 - 06:36 AM ET

CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group - 09/12 - 06:00 AM ET

CVTX: To Present At BioCentury's Biotech Industry Conference @ 16:00 ET [delayed] - 09/04 - 02:24 PM ET

CV Therapeutics initiates enrollment in Phase I cardiometabolic diseases trial - 09/04 - 12:49 PM ET

CV Therapeutics (CVTX) NewsBite - CV Therapeutics Begins Phase 1 Trial of CVT-3619 - 09/03 - 01:31 AM ET

CVTX: Begins Enrollment for Phase 1 Trial of CVT-3619 - 09/02 - 09:18 AM ET

CV Therapeutics Initiates Phase 1 Clinical Trial of CVT-3619, a Novel Potential Treatment for Cardiometabolic Diseases - 09/02 - 08:30 AM ET

CV Therapeutics (NGM: CVTX) NewsBite - CVTX Hits 52-Week High - 08/25 - 03:28 AM ET

CVTX: Positive Study Data re Ranolazine for LQT3 Syndrome Published - 08/19 - 08:43 AM ET

Journal of Cardiovascular Electrophysiology Publishes Data Showing Ranolazine Shortened QT Interval and Improved Cardiac Relaxation in Study of Patients With Long QT Syndrome - 08/19 - 08:30 AM ET

CV Therapeutics wins European approval for brand name Ranexa - 08/18 - 12:49 PM ET

CV Therapeutics Receives European Approval for the Brand Name Ranexa(R) - 08/14 - 04:01 PM ET

CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award - 08/14 - 01:15 PM ET

CV Therapeutics Big News to Come - 08/05 - 07:10 AM ET

Page 1 of 11     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index